Mustafa Nazıroğlu

49PUBLICATIONS
29CO-AUTHORS
Autonomic nervous systemMedical infection agents (incl. prions)Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Optical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 10, 2026
Brain-derived neurotrophic factor via TRPM2 inhibition reduces amyloid-beta-mediated increases of apoptosis and mitochondrial oxidative neurotoxicity in neuronal cells.

|Aug 06, 2026
Psalmotoxin-1, a novel TRPM2 channel antagonist, reduces age-related macular degeneration-caused mitochondrial oxidative damage and apoptosis in human retinal pigment epithelial (ARPE-19) cells.

|Jun 26, 2026
An In Vitro Evaluation of a New Approach in AMD: Effects of the Combination of Resveratrol and Anti-VEGFs on ARPE-19 Cells.

|Apr 29, 2026
Cisplatin Kills Ovarian Cancer Cells by Causing Mitochondrial Oxidative Stress and Death Through the TRPV1 Channel Stimulation: The Role of Eicosapentaenoic Acid.

|Feb 10, 2026
Selenium Nanoparticles Protect Retinal Pigment Epithelial Cells Against Experimental Age-Related Macular Degeneration-Induced Mitochondrial Oxidative Toxicity and Apoptosis Through the Modulation of the TRPM2 Channel.

Mehmet Argun, Mustafa Nazıroğlu

|Dec 14, 2025
Thymoquinone Reduces Bisphenol A-Induced Increases in Apoptosis and Oxidative Toxicity Through the Modulation of TRPM2 Channel Signaling Pathways in Human Granulosa Cells.

Mevlüt Bucak, Mustafa Nazıroğlu

Pageof 9

Frequent Collaborators

4 joint publications

Kenan Yıldızhan

3 joint publications

Ramazan Çınar

3 joint publications

Dilek Özkaya

2 joint publications

Mehmet Argun